Elliott Perry, O'Mahony Constantinos, Syrris Petros, Evans Alison, Rivera Sorensen Christina, Sheppard Mary N, Carr-White Gerald, Pantazis Antonios, McKenna William J
Inherited Cardiac Diseases Unit, University College London/The Heart Hospital (UCL Hospitals NHS trust), London, UK.
Circ Cardiovasc Genet. 2010 Aug;3(4):314-22. doi: 10.1161/CIRCGENETICS.110.937805.
Idiopathic dilated cardiomyopathy is a familial disorder in 25% to 50% of patients, but the genetic basis in the majority of cases remains unknown. Genes encoding desmosomal proteins, currently regarded as synonymous with another disorder, arrhythmogenic right ventricular cardiomyopathy, are known to cause left ventricular dysfunction, but their importance in unselected patients with unequivocal dilated cardiomyopathy is unknown. The objective of this study was to determine the prevalence of mutations in 5 desmosomal protein genes in patients with dilated cardiomyopathy.
We studied 100 unrelated patients with idiopathic dilated cardiomyopathy consecutively referred to a dedicated cardiomyopathy unit. Patients underwent clinical evaluation, ECG, echocardiography, exercise testing, 24-hour ambulatory ECG monitoring, and mutation screening of 5 genes implicated in arrhythmogenic right ventricular cardiomyopathy: plakoglobin, desmoplakin, plakophilin-2, desmoglein-2, and desmocollin-2. Of the 100 patients (mean age at evaluation, 46.8+/-13.8 years; range, 17.0 to 72.8 years; male sex, 63%), 5 were found to carry pathogenic desmosomal protein gene mutations. An additional 13 patients had sequence variants of uncertain pathogenic significance and were excluded from further comparative analysis. Patients harboring desmosomal gene mutations had a phenotype indistinguishable from the 82 noncarriers, with the exception of exercise-induced ventricular ectopy, which was more frequent in the desmosomal mutation carriers (P=0.033). None of the 5 carriers of desmosomal mutations fulfilled current diagnostic criteria for arrhythmogenic right ventricular cardiomyopathy, but 1 had fibrofatty change in the left ventricle at autopsy.
Heart failure caused by a dilated, poorly contracting left ventricle and arrhythmogenic right ventricular cardiomyopathy have been considered distinct clinicopathologic entities. This study suggests that both clinical presentations can be caused by mutations in desmosomal protein genes.
在25%至50%的特发性扩张型心肌病患者中,该病为家族性疾病,但大多数病例的遗传基础仍不清楚。已知编码桥粒蛋白的基因会导致左心室功能障碍,目前这些基因被认为与另一种疾病——致心律失常性右心室心肌病同义,但其在未经选择的明确扩张型心肌病患者中的重要性尚不清楚。本研究的目的是确定扩张型心肌病患者中5种桥粒蛋白基因突变的患病率。
我们连续研究了100例转诊至专门心肌病科室的非亲缘关系的特发性扩张型心肌病患者。患者接受了临床评估、心电图、超声心动图、运动试验、24小时动态心电图监测,以及对5个与致心律失常性右心室心肌病相关基因的突变筛查:桥粒斑珠蛋白、桥粒芯蛋白、盘状球蛋白2、桥粒胶蛋白2和桥粒糖蛋白2。在这100例患者中(评估时的平均年龄为46.8±13.8岁;范围为17.0至72.8岁;男性占63%),发现5例携带致病性桥粒蛋白基因突变。另有13例患者有意义未明的序列变异,被排除在进一步的比较分析之外。携带桥粒基因突变的患者与82例非携带者的表型无明显差异,但运动诱发的室性早搏在桥粒基因突变携带者中更常见(P=0.033)。5例桥粒基因突变携带者均不符合目前致心律失常性右心室心肌病的诊断标准,但有1例尸检时左心室有纤维脂肪变性。
由扩张且收缩功能不良的左心室引起的心力衰竭和致心律失常性右心室心肌病一直被认为是不同的临床病理实体。本研究表明,这两种临床表现都可能由桥粒蛋白基因突变引起。